Cerevel Therapeutics Holdings Inc. News
Analysts revamp AbbVie stock price target after earnings report
Here's what could happen to AbbVie's shares next.
5 Biotechs With Cash Runways Into 2025
In drug development, cash is king, especially during a market correction.
This Pfizer Spinout Is Leaving Nothing to Chance
Cerevel Therapeutics more than doubled its cash balance to keep pace with Karuna Therapeutics in a head-to-head showdown.
Cerevel Doubles on Progress With Schizophrenia Drug Test
Cerevel's treatment candidate for schizophrenia in testing showed meaningful improvement over placebo. The stock is higher.
Ceres (CERE) Stock Higher on License Agreement
Ceres (CERE) shares are gaining after the company announced a new licensing agreement with KWS SAAT SE.
Ceres (CERE) Stock Gains on Puerto Rico Expansion
Ceres (CERE) shares are higher following the announcement that the company expanded commercial evaluations of its improved forage hybrids in Puerto Rico.
Ceres (CERE) Flagged As Strong On High Volume
Trade-Ideas LLC identified Ceres (CERE) as a strong on high relative volume candidate
5 Stocks Under $10 Set to Soar
These under-$10 stocks look poised to break out and trade higher from current levels.
Ceres (CERE) Stock Spikes on New Patent
Ceres (CERE) shares are higher after being awarded a new patent for its iCODE development system.
Strong On High Relative Volume: Ceres (CERE)
Trade-Ideas LLC identified Ceres (CERE) as a strong on high relative volume candidate
Trade-Ideas: Ceres (CERE) Is Today's Strong On High Relative Volume Stock
Trade-Ideas LLC identified Ceres (CERE) as a strong on high relative volume candidate
Ceres (CERE): Today's Weak On High Volume Stock
Trade-Ideas LLC identified Ceres (CERE) as a weak on high relative volume candidate
Ceres (CERE) Stock Spikes After Being Awarded Soybean Genetic Sequence Patent
Ceres (CERE) shares are climbing after the agricultural biotech company received a patent for its genetic soybean sequence.
3 Stocks Pushing The Chemicals Industry Lower
TheStreet highlights 3 stocks pushing the Chemicals industry lower today.
4 Coal and Biofuel Stocks Investors Should Sell Right Now
Investors should take precautions when investing in both sectors.
3 Chemicals Stocks Moving The Industry Upward
TheStreet highlights 3 stocks that pushed the Chemicals industry
3 Stocks Pushing The Chemicals Industry Lower
TheStreet highlights 3 stocks pushing the Chemicals industry lower today.
3 Chemicals Stocks Pushing Industry Growth
TheStreet highlights 3 stocks that pushed the Chemicals industry
3 Stocks Pushing The Chemicals Industry Lower
TheStreet highlights 3 stocks pushing the Chemicals industry lower today.
3 Stocks Pushing The Chemicals Industry Lower
TheStreet highlights 3 stocks pushing the Chemicals industry lower today.
Cerevel Therapeutics Holdings Inc. News from TheStreet Pro
While AbbVie Is Busy Investing in Growth, How Tradable Is it?
The balance sheet is a semi-sloppy, but this company does cash flows well.
This Small Pharma Could Be Targeted, But Would Be Fine Alone, Too
Aurinia makes a great covered-call play as M&A in biotech heats up.
AbbVie Is Buying Cerevel Therapeutics, Which I Recommended Last Month. Now What?
If you bought then, you should be a seller now.
This Mid-Cap Biotech Stock Could Rise More Than 40% From Here
Trading volume has increased in the past three months, suggesting increased investor interest.
Breaking News
Many billionaire tech CEOs will be at Donald Trump’s inauguration (but not all)
One Silicon Valley leader will not be joining his Magnificent 7 CEO peers
Toyota has a dirty political secret that hurts its 'green' image
Toyota's 'squeaky clean' image as the Prius brand is a bit foggy.
Fidelity analyst unveils market forecast for 2025
The veteran analyst explains what could happen to markets in 2025.
Significant changes coming for Social Security payments in 2025
Here’s what retired Americans can expect for the year ahead.